IRON
Price
$47.98
Change
+$0.66 (+1.39%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
1.66B
64 days until earnings call
SRZN
Price
$8.50
Change
+$0.19 (+2.29%)
Updated
Jun 5, 04:58 PM (EDT)
Capitalization
73.98M
Interact to see
Advertisement

IRON vs SRZN

Header iconIRON vs SRZN Comparison
Open Charts IRON vs SRZNBanner chart's image
Disc Medicine
Price$47.98
Change+$0.66 (+1.39%)
Volume$9.32K
Capitalization1.66B
Surrozen
Price$8.50
Change+$0.19 (+2.29%)
Volume$100
Capitalization73.98M
IRON vs SRZN Comparison Chart
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. SRZN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Buy and SRZN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (IRON: $47.98 vs. SRZN: $8.64)
Brand notoriety: IRON and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 96% vs. SRZN: 42%
Market capitalization -- IRON: $1.66B vs. SRZN: $73.98M
IRON [@Biotechnology] is valued at $1.66B. SRZN’s [@Biotechnology] market capitalization is $73.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than SRZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 5 TA indicator(s) are bullish while SRZN’s TA Score has 4 bullish TA indicator(s).

  • IRON’s TA Score: 5 bullish, 3 bearish.
  • SRZN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IRON is a better buy in the short-term than SRZN.

Price Growth

IRON (@Biotechnology) experienced а +2.37% price change this week, while SRZN (@Biotechnology) price change was +1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

IRON is expected to report earnings on Aug 08, 2025.

SRZN is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($1.66B) has a higher market cap than SRZN($74M). IRON YTD gains are higher at: -25.363 vs. SRZN (-39.791). SRZN has higher annual earnings (EBITDA): -25.06M vs. IRON (-114.41M). IRON has more cash in the bank: 695M vs. SRZN (31M). SRZN has less debt than IRON: SRZN (1.53M) vs IRON (30.6M). SRZN has higher revenues than IRON: SRZN (10M) vs IRON (0).
IRONSRZNIRON / SRZN
Capitalization1.66B74M2,246%
EBITDA-114.41M-25.06M457%
Gain YTD-25.363-39.79164%
P/E RatioN/AN/A-
Revenue010M-
Total Cash695M31M2,242%
Total Debt30.6M1.53M2,004%
TECHNICAL ANALYSIS
Technical Analysis
IRONSRZN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TADGX80.65N/A
N/A
T. Rowe Price Dividend Growth Advisor
TRRSX18.91N/A
N/A
Nuveen Real Estate Sec Sel Retire
MEFIX13.55N/A
N/A
Martin Currie Emerging Markets FI
MOJOX15.39N/A
N/A
Donoghue Forlines Momentum I
VCRVX14.21-0.10
-0.70%
NYLI CBRE Global Infrastructure Inv Cl